Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
10.80
+0.25 (2.37%)
May 8, 2026, 1:46 PM CST

TPEX:4186 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
363.98353.49315.43276.9239.59
Other Revenue
0.810.680.5641.343.77
364.79354.17315.98318.24243.36
Revenue Growth (YoY)
3.00%12.09%-0.71%30.77%3.31%
Cost of Revenue
130.72110.21117.53125.66118.57
Gross Profit
234.07243.97198.46192.58124.79
Selling, General & Admin
183.34180.64177.47168.04182.08
Research & Development
13.3418.4916.7216.1445.51
Operating Expenses
205.08202.71196.02184.97227.59
Operating Income
28.9841.262.437.61-102.79
Interest Expense
-6.52-7.42-7.3-6.13-7.43
Interest & Investment Income
1.331.451.490.50.12
Currency Exchange Gain (Loss)
-1.21.354.1-0.56
Other Non Operating Income (Expenses)
3.360.170.31-3.470.38
EBT Excluding Unusual Items
27.1636.66-1.722.6-110.29
Gain (Loss) on Sale of Investments
--14.69-1.232.582.06
Gain (Loss) on Sale of Assets
--0.030.380.01-0.03
Asset Writedown
---9.15-1.89-6.05
Other Unusual Items
-0.660.330.39-0.14
Pretax Income
27.1622.6-11.393.69-114.44
Income Tax Expense
-0.89-0.27-0.710.524.08
Net Income
28.0522.88-10.683.17-118.53
Net Income to Common
28.0522.88-10.683.17-118.53
Net Income Growth
22.61%----
Shares Outstanding (Basic)
9090909090
Shares Outstanding (Diluted)
9090909090
Shares Change (YoY)
0.53%---11.05%
EPS (Basic)
0.310.25-0.120.04-1.32
EPS (Diluted)
0.310.25-0.120.04-1.32
EPS Growth
24.00%----
Free Cash Flow
19.774.370.67-27.87-63.28
Free Cash Flow Per Share
0.220.050.01-0.31-0.70
Gross Margin
64.17%68.88%62.80%60.51%51.28%
Operating Margin
7.95%11.65%0.77%2.39%-42.24%
Profit Margin
7.69%6.46%-3.38%1.00%-48.70%
Free Cash Flow Margin
5.42%1.23%0.21%-8.76%-26.00%
EBITDA
48.6856.3323.1230.97-77.72
EBITDA Margin
13.34%15.91%7.32%9.73%-31.94%
D&A For EBITDA
19.6915.0720.6923.3625.07
EBIT
28.9841.262.437.61-102.79
EBIT Margin
7.95%11.65%0.77%2.39%-42.24%
Effective Tax Rate
---13.98%-
Revenue as Reported
364.79354.17315.98318.24243.36
Advertising Expenses
-16.99---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.